Search

everythinglearnresearchcommunity

for

Search:↓

The combination of oral minoxidil, oral dutasteride, and mesotherapy is the most effective and safe for hair growth in AGA.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Microemulsions can improve minoxidil delivery and effectiveness for hair loss treatment.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

5% minoxidil significantly increases hair follicle density.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Botulinum neurotoxin A is effective and safe for treating various conditions, but more clinical trials are needed to fully assess its benefits and risks.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Redenyl lotion effectively promotes hair growth and improves quality of life for androgenetic alopecia patients.

Using both 5% spironolactone and 5% minoxidil together is safe and more effective for treating hair loss.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Combining microneedling with Minoxidil and Finasteride greatly improves hair growth and reduces hair loss in men.

The 5% minoxidil solution effectively treated hair loss with good tolerability.

Dutasteride 0.5 mg is safe and effective for long-term use in Korean men with hair loss.

Dutasteride is safe and effective long-term for male hair loss.

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

The method effectively measures drug impact on DHT levels in prostate treatments.

SIM01 significantly reduced post-COVID symptoms and is safe.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Using more than 5% minoxidil can help hair growth more, but results vary and side effects may increase.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Topical 5% minoxidil is effective and safe for treating androgenetic alopecia, especially in younger patients with early-stage hair loss.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

The combination of oral finasteride and topical 5% minoxidil effectively treats androgenic alopecia, especially after 3 months.